EFF and ASBMR Announce the Fourth Fellows Forum on Metabolic Bone Diseases

October 13-14, 2010, Toronto, Canada

On October 13-14, 2010, EFF and ASBMR will be co-sponsoring the Fourth Fellows Forum on Metabolic Bone Diseases in conjunction with the American Society for Bone and Mineral Research 2010 Annual Meeting, October 15-19, 2010, in Toronto, Canada.  The forum will be held at the Sheraton Centre Toronto Hotel the day before the ASBMR meeting starts and will provide endocrine fellows an opportunity to gain a better understanding of today’s challenges in current management of metabolic bone diseases from some of the world’s most acclaimed thought leaders.  There will be an equal balance of topics from both clinical and basic aspects of metabolic bone diseases.  Fellows are strongly encouraged to stay and attend the ASBMR 2010 Annual Meeting.

Program Directors will be asked to nominate one deserving fellow from their program to attend this sponsored event.  Air fare, hotel and meals will be covered for up to sixty participants, allowing for an intimate and informal education experience thanks to the generous support of unrestricted education grants from Amgen, Eli Lilly and Company, Novartis Pharma AG, sanofi-aventis and others. Fellows selected to attend will be announced no later than Monday, July 19, 2010.

Third Annual Fellows Forum in Metabolic Bone Diseases

In co-sponsorship with the American Society for Bone and Mineral Research (ASBMR), the Endocrine Fellows Foundation hosted the Third Annual Fellows Forum in Metabolic Bone Diseases on September 11, 2008, in Montreal, Quebec, Canada.  The forum took place the day before the ASBMR’s 30th Annual Meeting at the Le Centre Sheraton Hotel.

The distinguished faculty was selected to give the participants information that is on the cutting edge of our field in an interactive, informative and informal format.  The faculty included Clifford J. Rosen, M.D. (Genetics and Biology of Bone), Lawrence G. Raisz, M.D. (New Therapeutic Concepts in Osteoporosis), Mary L. Bouxsein, Ph.D. (Assessment of Bone Quality: New Technologies), John Adams, M.D. (The Basic Biology of Skeletal and Non-skeletal Actions of Vitamin D), Marjorie Luckey, M.D. (Causes of Osteoporosis: It Isn’t All Due to the Menopause) Michael R. McClung, M.D. (Quantitative Risk Assessment: The Future of Therapeutic Decision-Making), Lynda F. Bonewald, Ph.D. (The Osteocyte: What is it?  Where did it come from?  What does it do?), Stavroula Kousteni, Ph.D. (Biochemical Pathways of Bone Cells That Lead to Bone Build Up and Bone Breakdown), John P. Bilezikian, M.D.(Primary Hyperparathyroidism: New Concepts and New Approaches for 2008), Paul Miller, M.D. (What is Wrong with the Bones of Patients in Renal Failure and What We Can Do About It), and Ego Seeman, M.D., FRACP (The Periosteum: Do Bone Size and Shape Matter?).

EFF and ABSMR are grateful to Amgen, Eli Lilly, Novartis and Alliance for Better Bone Health (Procter & Gamble and sanofi-aventis) for their generous support of this forum.